[go: up one dir, main page]

WO2013019051A2 - Procédé de production d'un rétinoïde par un micro-organisme - Google Patents

Procédé de production d'un rétinoïde par un micro-organisme Download PDF

Info

Publication number
WO2013019051A2
WO2013019051A2 PCT/KR2012/006071 KR2012006071W WO2013019051A2 WO 2013019051 A2 WO2013019051 A2 WO 2013019051A2 KR 2012006071 W KR2012006071 W KR 2012006071W WO 2013019051 A2 WO2013019051 A2 WO 2013019051A2
Authority
WO
WIPO (PCT)
Prior art keywords
seq
gene encoding
retinoid
microorganism
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/006071
Other languages
English (en)
Korean (ko)
Other versions
WO2013019051A3 (fr
WO2013019051A9 (fr
Inventor
김선원
장희정
윤상활
하보경
류희경
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyeongsang National University GNU
Original Assignee
Gyeongsang National University GNU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyeongsang National University GNU filed Critical Gyeongsang National University GNU
Priority to US14/235,841 priority Critical patent/US9644217B2/en
Priority to CN201280042839.0A priority patent/CN103857786B/zh
Priority claimed from KR1020120083185A external-priority patent/KR101392159B1/ko
Publication of WO2013019051A2 publication Critical patent/WO2013019051A2/fr
Publication of WO2013019051A9 publication Critical patent/WO2013019051A9/fr
Publication of WO2013019051A3 publication Critical patent/WO2013019051A3/fr
Anticipated expiration legal-status Critical
Priority to US15/180,032 priority patent/US9834794B2/en
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes

Definitions

  • the present invention relates to a method for producing a retinoid from a microorganism having a retinoid producing ability.
  • Retinoids are a class of lipophilic isoprenoid molecules chemically associated with vitamin A.
  • the retinoid may be combined with an alcohol (eg, retinol), aldehyde (eg, retinal), carboxylic acid (eg, retinoic acid), or ester (eg, retinyl acetate) functional group to form ⁇ - It consists of inon rings and polyunsaturated side chains. They are known to play an essential role in human health, such as vision protection, bone development and regeneration, antioxidant effects, and skin aging prevention and reduce the risk of certain cancers.
  • Retinoids have received great attention in recent years as effective cosmetic and pharmaceutical ingredients for wrinkle improvement and skin disease treatment.
  • the retinoid market is estimated to be around $ 16 billion worldwide.
  • Chemically synthesized retinoids are representative commercial raw materials.
  • Retinol is produced from acidification or hydrolysis of retinal chemically synthesized by reduction of pentadiene derivatives.
  • this chemical process has disadvantages such as complicated purification steps and formation of unwanted byproducts.
  • Animals produce retinoids from carotenoids obtained from fruits and vegetables, while plants cannot synthesize retinoids.
  • the entire route of retinoid synthesis is only possible in microorganisms comprising bacteriododocin or proteorodosin with retinal as a prosthetic group.
  • microorganisms produce a protein-binding form of retinal and are therefore not suitable for mass production of free retinoids.
  • enzymes for biological production, but no successful results.
  • biotechnological methods for retinoid production using metabolically transformed microorganisms there is a need for the development of biotechnological methods for retinoid production using metabolically transformed microorganisms.
  • Retinoids are chemically very unstable due to their reactive conjugated double bonds and are easily oxidized and isomerized by heat, oxygen and light. Retinoids are also readily degraded biologically through retinoic acid. Therefore, there is a need for a method of producing retinoids more efficiently.
  • One aspect provides a method for efficiently producing retinoids from microorganisms.
  • One aspect includes the steps of culturing a microorganism having a retinoid production capacity in a medium containing a lipophilic substance; And separating the retinoid from the lipophilic substance. It provides a method for producing a retinoid from a microorganism.
  • the method includes culturing the microorganism having the retinoid production capacity in a medium containing a lipophilic substance.
  • microorganism can be a cell that can be cultured in a liquid medium.
  • the microorganism may be one that can be cultured in a liquid medium as prokaryotic cells, eukaryotic cells, or isolated animal cells.
  • the microorganism may be, for example, a bacterium, fungus, or a combination thereof.
  • the bacteria may be Gram positive bacteria, Gram negative bacteria, or a combination thereof.
  • Gram-negative bacteria can be of the genus Escherichia .
  • Gram-positive bacteria can be of the genus Bacillus, Corynebacterium, lactic acid bacteria or combinations thereof.
  • the fungus may be yeast, cloberomyces, or a combination thereof.
  • the microorganism may be a natural or foreign gene is introduced.
  • the foreign gene can be a gene involved in retinoid production, such as one or more genes of the MEP or MVA pathway.
  • Animal cells may be those used for recombinant protein production. For example, it can be CHO cells, BHK cells, or a combination thereof.
  • the Escherichia genus microorganism having the retinoid producing ability may be a native Escherichia microorganism or a transformed Escherichia genus microorganism.
  • Natural microorganisms of the genus Escherichia are known to have a MEP pathway as an intrinsic retinoid synthesis pathway.
  • the transformed Escherichia genus microorganism may be introduced with a gene associated with the intrinsic MEP pathway of retinoid synthesis, a gene associated with the foreign MVA pathway, or a combination thereof.
  • the MVA pathway gene may be a gene encoding an enzyme of the foreign mevalonate pathway involved in producing IPP from acetyl-CoA.
  • Fig. 1 is a diagram schematically showing the MEP pathway of retinal biosynthesis and foreign MVA pathway.
  • the natural Escherichia genus microorganism can be, for example, Escherichia coli.
  • the E. coli may be DH5 ⁇ , MG1655, BL21 (DE), S17-1, XL1-Blue, BW25113, or a combination thereof.
  • Transformed Escherichia microorganisms encode, for example, acetyl-CoA acetyltransferase / hydroxymethylglutaryl (HMG) -CoA reductase from Enterococcus faecalis of SEQ ID NO: 1
  • SEQ ID NO: 4 Gene encoding a phosphomevalonate kinase derived from Streptococcus pneumoniae, gene encoding the mevalonate diphosphate decarboxylase derived from Streptococcus pneumoniae of SEQ ID NO: 5, iso derived from E.
  • IPP coli Fenthenyl diphosphate
  • Pantoea agglomerans gene of SEQ ID NO: 7 Gene encoding the geranyl geranyl pyrophosphate (GGPP) synthase, gene encoding the phytoene synthase derived from Pantoea agglomerans of SEQ ID NO: 8, Pantoea agglomer of SEQ ID NO: 9 And a gene encoding a phytoene dehydrogenase derived from Lance, and a gene encoding a lycopene- ⁇ -cyclase derived from Pantoea ananatis of SEQ ID NO: 10.
  • the transformed Escherichia genus microorganism is transformed with the genes of SEQ ID NOs: 1 to 10, and also encodes the ⁇ -carotene monooxygenase from uncultured marine bacterium 66A03 of SEQ ID NO: 13 , A gene encoding ⁇ -carotene 15,15'-monooxygenase from the musculus mouse of SEQ ID NO: 14, brp-like protein 2 from Natronomonas pharaonis ATCC35678 of SEQ ID NO: 15 (brp-like protein 2: brp2) and a gene encoding ⁇ -carotene monooxygenase from Halobacterium salinarum ATCC700922 of SEQ ID NO: 16 or 17 It may be further transformed with one or more genes.
  • the microorganism may be to produce a retinoid, which is further transformed with a gene encoding IPP isomerase from Haematococcus pluvialis of SEQ ID NO: 12.
  • the microorganism having a retinoid production ability may be transformed with a gene encoding E. coli derived 1-deoxyxylulose-5-phosphate (DXP) synthase (dxs). Since DXP is an enzyme that corresponds to the rate determining step in the intrinsic MEP pathway, the additional gene encoding the DXP synthase allows microorganisms to produce high concentrations of ⁇ -carotene.
  • DXP E. coli derived 1-deoxyxylulose-5-phosphate synthase
  • E. coli DH5 ⁇ / pTDHB / pSNA of Accession No. KCTC 11254BP (deposited KOREAN COLLECTION FOR TYPE CULTURE, January 2. 2008) or Accession No. KCTC 11255BP E. coli DH5 ⁇ / pTDHBSR / pSNA (KOREAN COLLECTION FOR TYPE CULTURE, deposited on Jan. 2, 2008).
  • E. coli DH5 ⁇ / pTDHBSR / pSNA can produce high productivity of retinoids from carbon sources in the medium.
  • the microorganism is Enterococcus faecalis of SEQ ID NO: 1 ( Enterococcus faecalis Gene encoding the acetyl-CoA acetyltransferase / hydroxymethylglutaryl (HMG) -CoA reductase derived from c), HMG-CoA synthase from Enterococcus faecalis of SEQ ID NO: 2, sequence Streptococcus pneumoniae (number 3 Streptococcus pneumoniae Gene encoding the mevalonate kinase derived from), phosphomevalonate kinase derived from Streptococcus pneumoniae of SEQ ID NO: 4, mevalonate diphosphate dekar from Streptococcus pneumoniae of SEQ ID NO: 5 Gene encoding a carboxylase, isopentenyl diphosphate (IPP) isomerase derived from Escherichia coli of SEQ ID NO: 6, panto
  • Uncultured marine bacterium 66A03 of SEQ ID NO: 13 Gene encoding the derived ⁇ -carotene monooxygenase may be one having a nucleotide sequence of SEQ ID NO: 32 optimized codon use in E. coli.
  • retinoids refers to a class of chemicals chemically related to vitamin A.
  • the structure of the retinoid consists of cyclic end groups, polyene side chains and polar end groups.
  • Many retinoids are chromophores.
  • Various retinoids can be produced by changing side chains and end groups.
  • the retinoid may be retinal, retinol, retinoic acid, retinyl acetate, or a combination thereof.
  • the retinoid may be an in vivo degradation product of retinal, retinol, retinoic acid, retinyl acetate, or a combination thereof.
  • the retinoid is a substance having a basic carbon number of 20, and the final carbon number may vary depending on the fatty acid auxiliary group to be bonded.
  • the final carbon number may be 22 for acetate bonding and 38 for oleic acid bonding.
  • the lipophilic substance may be one having lipophilic as an organic compound having 8 to 50 carbon atoms.
  • the lipophilic material may be an alkane compound having 8 to 50 carbon atoms, a compound of Formula 1; A compound of Formula 2; Or combinations thereof:
  • R 2 Each independently represent alkyl having 8 to 50 carbon atoms, and CO represents a carbonyl group
  • R 3 , R 4 and R 5 each independently represent alkyl having 8 to 50 carbon atoms, and CO represents a carbonyl group).
  • Alkanes having 8 to 50 carbon atoms may be linear alkanes, branched alkanes, cyclic alkanes, or combinations thereof.
  • the alkane compound is, for example, 8 to 46, 8 to 40, 8 to 36, 8 to 30, 8 to 26, 8 to 20, 8 to 16, 8 to 12, 8 to 10, 10 to 50, 10 to 46, 10 to 40, 10 to 36, 10 to 30, 10 to 26, 10 to 20, 10 to 16, 10 to 12, 10 to 50, 10 to 46, 12 to 50, 12 to 46, 12 to 36, It may be 12 to 30, 12 to 26, 12 to 20, or 12 to 16 alkane compound.
  • Straight alkanes contain 8 (octane), 10 (decane), 12 (dodecane), 14 (tetradecane), 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50 alkanes, or a combination thereof.
  • Branched alkanes have 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50 alkanes, Or combinations thereof.
  • Branched alkanes may be saturated analogs of terpene compounds. For example, it may be phytoscualan.
  • the combination of straight alkanes, branched alkanes, and cyclic alkanes may be mineral oil.
  • the mineral oil may be a mixture of alkanes having 15 to 40 carbon atoms from non-vegetable raw materials (minerals).
  • Alkanes having 15 to 40 carbon atoms include 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, It may be a mixture of two or more of alkanes of 36, 37, 38, 39, 40.
  • the mineral oil may be light mineral oil or heavy mineral oil.
  • Light mineral oils generally have a density of 880-920kg / m 3 and a specific gravity of 820-860 kg / m 3 at 20 ° C and a fluid viscosity of 14-18cst at 40 ° C.
  • By weight mineral oil (heavy mineral oil) is of generally a density of 920kg / m 3 and a specific gravity of 860 ⁇ 900 kg / m 3, liquid viscosity of 85cst at 65 ⁇ 40 °C at 20 °C material.
  • One And R 2 are each independently straight, branched or cyclic alkyl having 8 to 50 carbon atoms.
  • R One And R 2 are each independently alkyl having 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48 or 50 Can be.
  • R 1 and R 2 each have 8 to 50 carbon atoms, for example, 8 to 46, 8 to 40, 8 to 36, 8 to 30, 8 to 26, 8 to 20, 8 to 16, 8 to 12, 8 carbon atoms.
  • R 1 may be straight alkyl having 13 carbon atoms and R 2 may be isopropyl.
  • R 1 may be an ethylpentyl group and R 2 may be cetyl.
  • R 3 , R 4 and R 5 are each independently straight, branched or cyclic alkyl having 8 to 50 carbon atoms.
  • R 3 , R 4 , and R 5 are each having 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48 or 50 alkyl.
  • the compound may have R 3 , R 4 , and R 5 , each having 8 to 50 carbon atoms, for example, 8 to 46, 8 to 40, 8 to 36, 8 to 30, 8 to 26, 8 to 8 carbon atoms.
  • the lipophilic material may be octane, decane, dodecane, tetradecane, phytoscualan, mineral oil, isopropyl myristate, cetyl ethylhexanoate, dioctanoyl decanoyl glycerol, squalane, or a combination thereof.
  • lipophilic substances can increase the productivity of retinoids by microorganisms.
  • the lipophilic substance may be one that does not affect or grows little in the growth of microorganisms.
  • Cultivation may be in synthetic, semisynthetic, or complex culture media.
  • a culture medium a medium consisting of a carbon source, a nitrogen source, vitamins and minerals can be used.
  • a Man-Rogosa-Sharp (MRS) liquid medium or a liquid medium added with milk can be used.
  • Starch glucose, sucrose, galactose, fructose, glycerol, glucose or mixtures thereof may be used as the carbon source of the medium.
  • glycerol can be used as the carbon source.
  • nitrogen source ammonium sulfate, ammonium nitrate, sodium nitrate, glutamic acid, casamino acid, yeast extract, peptone, tryptone, soybean meal or mixtures thereof may be used.
  • the mineral may be sodium chloride, dipotassium phosphate, magnesium sulfate or mixtures thereof.
  • the culture is in a fermentor, it is preferable to use glucose as the carbon source of the medium.
  • glucose is preferable to use in the case of in vitro culture.
  • glycerol is preferably used as the carbon source of the medium.
  • Each of the carbon source, nitrogen source, and mineral in the microbial culture medium may use, for example, 10 to 100 g, 5 to 40 g, and 0.5 to 4 g per liter.
  • the vitamin added to the conventional culture medium may be vitamin A, vitamin B, vitamin C, vitamin D, vitamin E or mixtures thereof.
  • the vitamin may be added to the conventional culture medium with the above-mentioned carbon source, nitrogen source, minerals, etc., or separately added to the medium prepared by sterilization.
  • Cultivation may be carried out under conventional E. coli culture conditions. Incubation is for example about 15-45 °C, for example 15-44 °C, 15-43 °C, 15-42 °C, 15-41 °C, 15-40 °C, 15-39 °C, 15-38 °C, 15-37 ° C, 15-36 ° C, 15-35 ° C, 15-34 ° C, 15-33 ° C, 15-32 ° C, 15-31 ° C, 15-30 ° C, 20-45 ° C, 20-44 ° C, 20-43 ° C, 20-42 ° C, 20-41 ° C, 20-40 ° C, 20-39 ° C, 20-38 ° C, 20-37 ° C, 20-36 ° C, 20-35 ° C, 20-34 ° C, 20-33 ° C, 20-32 ° C, 20-31 ° C, 20-30 ° C, 25-45 ° C, 20
  • Centrifugation or filtration may be performed to remove the culture medium in the culture and recover or remove only the concentrated cells, and this step may be performed according to the needs of those skilled in the art.
  • the concentrated cells can be preserved so as not to lose their activity by freezing or lyophilizing according to a conventional method.
  • the culture may be in a medium containing glycerol as a carbon source.
  • Glycerol may be the only carbon source in the medium.
  • 0.5-5.0% (w / v), e.g. 0.5-4.5% (w / v), 0.5-4.0% (w / v), 0.5-3.5% (w / v), 0.5-3.0% (w / v), 0.5-2.5% (w / v), 0.5-2.0% (w / v), 1-5.0% (w / v), 1-4.5% (w / v), 1-4.0% (w / v), 1-3.5% (w / v), 1-3.0% (w / v) or 1-2.5% (w / v) may be made in a medium containing glycerol.
  • the medium may be YT medium added with glycerol and arabinose.
  • YT medium may comprise 1.6 wt% tryptone, 1 wt% yeast
  • Cultivation may be performed in a culture medium in the presence of a lipophilic substance, for example, with a dodecane phase of a lipophilic substance placed on the surface of the medium. Cultivation can be carried out while being agitated.
  • 100 to 300 rpm for example, 100 to 280 rpm, 100 to 260 rpm, 100 to 240 rpm, 100 to 220 rpm, 100 to 200 rpm, 100 to 180 rpm, 100 to 160 rpm, 100 to 140 rpm, 100 to 120 rpm, 120 to 120 300 rpm, 120 to 280 rpm, 120 to 260 rpm, 120 to 240 rpm, 120 to 220 rpm, 120 to 200 rpm, 120 to 180 rpm, 120 to 160 rpm, 120 to 140 rpm, 150 to 300 rpm, 150 to 280 rpm, 150 to 260 rpm, 150 to 240 rpm, It may be stirred at 150 to 220 rpm, 150 to 200 rpm, 150 to 180 rpm, 140 to 160 rpm, 200 to 300 rpm, 200 to 280 rpm, 200 to 260 rpm, 200 to 240 rpm, 200 to 220 rpm, or
  • the lipophilic material such as dodecane
  • the lipophilic substance may be dispersed in a medium to increase the area in contact with the microorganisms, thereby allowing the retinoid to be efficiently separated from the cells during the cultivation, thereby stabilizing and / or lysing.
  • the retinoid production may peak at some point and then decrease. This may be because additional retinoid synthesis is stopped during the stagnant state of microbial growth, while its oxidative degradation occurs in the cell.
  • the produced retinoid may be absorbed onto the lipophilic substance such as dodecane before being degraded in the cell, thereby improving retinoid production.
  • the lipophilic material such as the dodecane phase, may be one that is hydrophobic and has low volatility for extraction of hydrophobic retinoids without affecting the cell growth of Escherichia microorganisms.
  • 2 shows the conversion of ⁇ -carotene to retinoids including retinal, retinol, retinoic acid, and retinyl esters.
  • the volume ratio of the medium to the lipophilic material is not limited to a specific range of ratios, for example, the volume ratio of the medium to the lipophilic material is 1: 0.1-3.0, 1: 0.2-3.0, 1: 0.5-3.0, 1: 1.0-3.0, 1: 1.5-3.0, 1: 2.0-3.0, 1: 2.5-3.0, 1: 0.2-2.5, 1: 0.2-2.0, 1: 0.2-1.5, 1: 0.2-1.0, 1: 0.2-0.5, 1: 0.5-2.5, 1: 0.5-2.0, 1: 0.5-1.5, 1: 0.5-1.0, 1: 0.8-2.5, 1: 0.8-2.0, 1: 0.8-1.5, 1: 0.8-1.2, 1: 0.8- 1.0 and the like are possible.
  • the medium comprises a concentration of about 2.0% glycerol, the genus Escherichia microorganism is E. coli DH5 ⁇ or MG1655, the culturing step is a culture medium of about 7 ml, about 29 °C It may be to.
  • the method also includes the step of separating the retinoid from the lipophilic phase. It is well known in the art to separate such retinoids such as retinal, retinol, retinoic acid, retinyl esters, or combinations thereof. For example, it can be separated by ion exchange chromatography, HPLC, or the like. Specifically, in order to obtain a high-purity product after extraction with a solvent such as acetone after recovering the cells may be separated and purified through HPLC or crystallization operation.
  • a solvent such as acetone
  • One embodiment comprises the steps of culturing the Escherichia genus microorganism having a retinoid production capacity in a medium containing a lipophilic substance; And separating the retinoid from the lipophilic substance, wherein the lipophilic substance is an alkane compound having 8 to 50 carbon atoms, a compound of Formula 1, a compound of Formula 2, or a combination thereof. It may be a method for producing a retinoid from.
  • retinol can be produced with high efficiency.
  • Fig. 1 is a diagram schematically showing the MEP pathway of retinal biosynthesis and the foreign MVA pathway.
  • retinoids including retinal, retinol, retinoic acid, and retinyl esters.
  • Figure 3 shows retinal production, ⁇ -carotene production and cell growth of E. coli, including pT-HB, pT-HBblh, pT-HBbrp, pT-HBbrp2, pT-HBBCMO1, and pT-HBSR.
  • E. coli including pT-HB, pT-HBSR, pT-DHB, and pT-DHBSR, and pT-DHB, or E. coli, including pT-DHBSR, with pS-NA, the MVA pathway plasmid. Carotene production and cell growth.
  • 5 shows retinoid production and cell growth of various E. coli strains with pT-DHBSR and pS-NA.
  • FIG. 6 shows retinoid production and cell growth of Escherichia coli with pT-DHBSR and pS-NA according to the culture test volume.
  • FIG. 7 shows the retinoid production and cell growth of E. coli with pT-DHBSR and pS-NA at different culture temperatures.
  • 9 and 10 show retinoid production and cell growth according to the concentration of glycerol, the carbon source of E. coli, including pT-DHBSR and pS-NA.
  • 11 and 12 show the results of retinoid production and cell growth of various E. coli strains in the presence of dodecane.
  • FIG. 13 shows the retinoid production and cell growth of Escherichia coli (pT-DHBSR / pS-NA) according to the concentration of glycerol as a carbon source in a two-phase culture comprising 1 mL dodecane on 5 ml culture medium.
  • FIG. 14 shows retinoid production and cell growth according to dodecane volume of Escherichia coli (pT-DHBSR / pS-NA) in two-phase culture.
  • FIG. 15 shows the distribution of retinoids according to the incubation time and dodecane volume of Escherichia coli (pT-DHBSR / pS-NA) in two-phase culture as a percentage of each component relative to the total retinoid.
  • FIG. 16 shows the effect of dodecane addition on beta-carotene production and cell growth of Escherichia coli with pT-DHB and pS-NA.
  • 17 and 18 are diagrams showing the results of retinoid production and cell growth of Escherichia coli (pT-DHBSR / pS-NA) in the presence of various alkanes.
  • 19, 20 and 21 is a diagram showing the results of the retinoid production, cell growth, cell specific retinoids (cell specific retinoids productivity) of E. coli (pT-DHBSR / pS-NA) in the presence of various volumes of light mineral oil.
  • 22 and 23 are diagrams showing the results of retinoid production and cell growth of Escherichia coli (pT-DHBSR / pS-NA) in the presence of heavy mineral oil.
  • 24 and 25 are diagrams showing the results of retinoid production and cell growth of Escherichia coli (pT-DHBSR / pS-NA) when cultured by tilting the test tube in the presence of heavy mineral oil.
  • FIG. 26 shows the cell growth and pH of Escherichia coli (pT-DHBSR / pS-NA) in the presence of a skin-friendly lipophilic substance.
  • FIG. 27 and FIG. 28 are diagrams showing the results of retinoid production of Escherichia coli (pT-DHBSR / pS-NA) according to various kinds and amounts of skin-friendly lipophilic substances.
  • E. coli DH5 ⁇ was used for gene cloning and retinoid production.
  • E. coli MG1655, BL21 (DE3), XL1-Blue, S17-1 and BW25113 were used to find the optimal strain for retinol production.
  • Cultivation for retinoid production was performed using a stirred incubator at 29 ° C. and 250 rpm in 2YT medium (16 g tryptone per liter, 10 g yeast extract, and 5 g NaCl). Glycerol and arabinose as primary and secondary carbon feedstocks, respectively, were added at concentrations of 0.5% to 2% (w / v) and 0.2% (w / v), respectively.
  • Glucose, galactose, xylose and maltose were compared with glycerol as the carbon feedstock for retinoid production.
  • Empicillin 100 ⁇ g / mL
  • chlorampeticol 50 ⁇ g / mL
  • Cultivation was performed in test tubes containing 7 mL medium. Cell growth was determined by measuring optical density at 600 nm (OD 600 ).
  • OD 600 optical density at 600 nm
  • ⁇ -carotene and retinoids were extracted from bacterial cell pellets with acetone.
  • the dodecane phase with retinoids was collected and centrifuged at 14,000 rpm for 10 minutes to remove all cell debris.
  • Acetone extract and dodecane phase were analyzed by HPLC (LC-20A, Shimadzu, Kyoto, Japan) at detection wavelengths of 370 nm (retinal), 340 nm (retinol and retinyl acetate) and 454 nm ( ⁇ -carotene).
  • E. coli which has an MEP pathway, additionally introduces a gene encoding DXP synthase, which is an enzyme corresponding to the rate determining step, into E. coli, and simultaneously encodes a gene encoding an enzyme that participates in the mevalonate pathway. Selected from the source and introduced, ⁇ -carotene high productivity E. coli was prepared.
  • Table 2 shows the primer sequences and restriction enzymes used for cloning the genes of Table 1.
  • mvaK1, mvaK2, and mvaD existed on the chromosome as one operon, and PCR cloning of the operon was performed at once without the PCR cloning of each gene.
  • the genes of Table 1 were amplified by PCR using the primers listed in Table 3 and using the chromosomal DNA of the strain containing the gene as a template.
  • the amplified product was introduced into the pSTV28 vector (Takara Korea, Korea) (SEQ ID NO: 45) using the restriction enzymes listed in Table 2 to prepare a vector pSNA.
  • the vector pSNA contains all of the genes encoding enzymes of the mevalonate pathway that can produce IPP from acetyl-CoA.
  • the gene encoding the enzyme involved in synthesizing ⁇ -carotene from the IPP used in this section and the DXP synthase gene, which is an enzyme in the rate determining step of the MEP pathway, are shown in Table 3 below.
  • crtB and crtI exist on the chromosome as one operon, and PCR cloning of the operon was performed at once without PCR cloning of each gene.
  • the genes of Table 3 were amplified by PCR using the primers listed in Table 4 and using the chromosomal DNA of the strain containing the gene as a template.
  • the amplified product was introduced into the pTrc99A vector (Genbank License No. M22744) (SEQ ID NO: 30) using the restriction enzymes listed in Table 4 to prepare a vector pT-DHB.
  • the vector pTDHB contains both the gene encoding the enzyme involved in synthesizing ⁇ -carotene from IPP and the DXP synthase (dxs) gene, which is an enzyme in the rate determining step of the MEP pathway.
  • all genes except dxs among the genes of Table 3 were introduced into the pTrc99A vector using the restriction enzymes listed in Table 4 to prepare a vector pT-HB.
  • the vectors pT-HBSR, pT-HBBcmo1, pT-HBbrp2, pT-HBblh and pT-HBbrp are vectors in which SR, Bcmo1, brp2, blh and brp genes are introduced into the pT-HB vector, respectively. It contains all the genes that encode enzymes involved in synthesizing retinal.
  • the SR gene from pT-HBSR was cut with Spe I and inserted into the corresponding portion of pT-DHB to obtain pT-DHBSR.
  • Retinal is a recombinant that produces ⁇ -carotene E. coli can be produced by introducing a BCM (D) O gene encoding ⁇ -carotene mono (di) oxygenase.
  • BCM (D) O gene encoding ⁇ -carotene mono (di) oxygenase.
  • Halobacterium spp. Halobacterium sp
  • NRC-1 blh And brp Genes
  • Natronomymonas pharaonics Natronomonas pharaonis
  • brp2 Genes Vertebrate Moose Musculus Musculus
  • Bcmo1 BCM (D) O gene from the gene was cloned.
  • the inventors also note that uncultured marine bacteria 66A03 blh Codon-optimized BCDO gene (SR) was synthesized based on the amino acid sequence of the gene.
  • the BCM (D) O gene was used to prepare retinal synthetic plasmids pT-HBblh, pT-HBbrp, pT-HBbrp2, pT-HBBcmo1 and pT-HBSR, respectively.
  • Recombinant E. coli cells containing each retinal plasmid were incubated at 29 ° C. for 48 hours in 2YT medium containing 0.5% (w / v) glycerol and 0.2% (w / v) arabinose as the carbon source.
  • Figure 3 shows retinal production, ⁇ -carotene production and cell growth of E. coli, including pT-HB, pT-HBblh, pT-HBbrp, pT-HBbrp2, pT-HBBCMO1, and pT-HBSR.
  • White bars and gray bars represent the values at 24 hours and 48 hours, respectively.
  • E. coli comprising pT-HBblh, pT-HBbrp, or pT-HBSR produced 2.2, 0.8, or 1.4 mg / L of retinal at 24 hours, respectively.
  • retinal production of Escherichia coli containing pT-HBblh or pT-HBbrp decreased to 0.7 or 0.4 mg / L, respectively, at 48 hours, whereas the retinal production of Escherichia coli (pT-HBSR) was slightly increased.
  • the decrease in retinal production after 24 hours may be due to intracellular oxidative degradation of the retinal.
  • the amount of retinal obtained from the culture depends on both intracellular synthesis and degradation of the retinal.
  • E. coli containing pT-HBblh or pT-HBbrp the retinal production rate after 24 hours of incubation time will be lower than their degradation rate. Trace amounts of retinal were detected in E. coli strain cultures containing pT-HBbrp2 or pT-HBBcmo1.
  • E. coli (pT-HB) without the BCM (D) O gene produced 35 mg / L of ⁇ -carotene and no retinal. Because ⁇ -carotene is just the precursor of retinal, the ⁇ -carotene consumption by BCM (D) O would be exactly proportional to the retinal production if there was retinal degradation. Since ⁇ -carotene remained in the culture of E.
  • SR enzyme was selected for retinal production in further experiments.
  • Cell growth was not affected by overexpression of the BCM (D) O gene, except for the N. pharaonis brp gene, which showed growth retardation.
  • Retinal building blocks, IPP and DMAPP can be synthesized in E. coli via the inherent MEP pathway and the foreign MVA pathway (FIG. 1). It is reported that 1-deoxy-d-xylose-5-phosphate (DXP) synthesis is an important rate-limiting step in the MEP pathway. Thus, overexpression of D XP synthase (encoded by dxs) increased lycopene and ⁇ -carotene production in our previous invention.
  • the pT-DHBSR was prepared by introducing the dxs gene before the MEP pathway in pT-HBSR.
  • FIG. 4 shows the retinal production of pT-DHB, or E. coli, including pT-DHBSR, with pS-NA, which is E. coli, including pT-HB, pT-HBSR, pT-DHBSR, and pT-DHBSR; ⁇ -carotene production and cell growth.
  • White bars and gray bars represent the values at 24 hours and 48 hours, respectively.
  • Escherichia coli containing an additional foreign MVA pathway produced 8.7 mg / L retinal at 48 hours, which is four times higher than the production of Escherichia coli (pT-DHBSR).
  • pT-DHBSR Escherichia coli
  • retinal in addition to the biological degradation of the retinal.
  • the formation of other retinoids derived from retinal by any enzyme in E. coli is contemplated.
  • retinal can be converted to retinol, retinoic acid and retinyl esters by cellular enzymatic reactions (FIG. 2)
  • retinal derivatives in E. coli cultures were analyzed. The formation of derivatives except retinoic acid was confirmed and the production of retinal, retinol and retinyl acetate was measured in further experiments.
  • E. coli strains The effect of E. coli strains on the production of retinoids including retinal, retinol and retinyl acetate was investigated. Retinoid production was performed using five E. coli strains, MG1655, DH5 ⁇ , XL1-Blue, S17-1, and BL21 (DE3), including pT-DHBSR and pS-NA. Table 5 shows the characteristics of the six E. coli strains, including the five strains.
  • FIG. 5 shows retinoid production and cell growth of five E. coli strains with pT-DHBSR and pS-NA. Cultivation was performed at 29 ° C. for 48 hours in 2YT medium containing 0.5% (w / v) glycerol and 0.2% (w / v) arabinose. Retinal, retinol, and retinyl acetate are shown in light gray, dark gray, and black, respectively, and in cell growth, MG1655, DH5 ⁇ , XL1-Blue, S17-1, and BL21 (DE3), respectively, ⁇ , ⁇ , ⁇ , ⁇ and ⁇ .
  • E. coli DH5 ⁇ showed the highest amount of retinoid as 40 mg / L at 36 hours, and E. coli S17-1 and XL1-Blue then produced about 22 mg / L retinoids. However, very small amounts of retinoids were obtained with E. coli MG1655 and BL21 (DE3). Therefore, E. coli DH5 ⁇ was selected as the retinoid producing strain.
  • FIG. 6 shows retinoid production and cell growth of Escherichia coli with pT-DHBSR and pS-NA according to test volume.
  • retinal, retinol, and retinyl acetate are shown in light gray, dark gray and black, respectively, and test volumes 3, 5, 7 mL, and 10 mL, respectively, in cell growth.
  • test volumes 3, 5, 7 mL, and 10 mL, respectively, in cell growth.
  • ⁇ . Cultivation was performed at 29 ° C. for 48 hours in 2YT medium containing 0.5% (w / v) glycerol and 0.2% (w / v) arabinose.
  • retinoid production peaked faster (corresponding to higher dissolved oxygen), and probably decreased faster due to its oxidative degradation. Both cell growth and retinoid production were delayed at a test volume of 10 mL, but small product degradation was observed. The optimal test volume for retinoid production was found to be 7 mL.
  • FIG. 7 shows the retinoid production and cell growth of E. coli with pT-DHBSR and pS-NA at different culture temperatures.
  • retinal, retinol, and retinyl acetate are shown in light gray, dark gray and black, respectively, and in cell growth the incubation temperatures of 29 ° C, 34 ° C and 37 ° C are indicated by ⁇ , ⁇ , ⁇ , respectively.
  • Cultivation was performed for 48 hours in 2YT medium containing 0.5% (w / v) glycerol and 0.2% (w / v) arabinose.
  • retinoid production was affected by incubation temperature and the highest production was obtained at 29 ° C.
  • FIG. 8 shows the retinoid production and cell growth of Escherichia coli with pT-DHBSR and pS-NA according to the carbon source.
  • retinal, retinol, and retinyl acetate are shown in light gray, dark gray and black, respectively, and have no carbon source, carbon source glycerol, glucose, xylose, maltose, and galactose, respectively, in cell growth.
  • ⁇ , ⁇ , ⁇ , and ⁇ Cultivation was performed at 29 ° C. for 48 hours in 2YT medium containing 0.2% (w / v) arabinose and 0.5% (w / v) glycerol, glucose, xylose, maltose, or galactose.
  • glycerol was the best carbon source for retinoid production.
  • glucose or galactose was used as the carbon source, the production of retinoids was lower than without the carbon source.
  • E. coli DH5 ⁇ (pT-DHBSR / pSNA) was grown at 29 ° C. in 2YT medium containing 0.0% to 2.0% (w / v) glycerol.
  • retinoids (retinal, retinol and retinyl acetate) of E. coli, including pT-DHBSR and pS-NA. Retinal, retinol and retinyl acetate are shown in light gray, dark gray and black, respectively.
  • FIG. 10 shows cell growth of Escherichia coli including pT-DHBSR and pS-NA.
  • the provided glycerol concentrations of 0%, 0.5%, 1%, and 2% are indicated by ⁇ , ⁇ , ⁇ , and ⁇ , respectively.
  • strains transformed with pT-DHBSR / pSNA for the six strains of Table 7 were used, 1 ml of dodecane was added to 5 ml of medium and cultured according to the conditions described in "Bacteria strains and culture conditions".
  • a medium 2YT medium containing 0.2% (w / v) arabinose and 0.5% (w / v) glycerol was used.
  • FIG. 11 is a view showing the retinoid production results according to different retinoid production strains in the presence of dodecane.
  • the most retinoids were produced in DH5 ⁇ and MG1655.
  • cell growth and retinoid production were increased compared to the case where dodecane was not added.
  • Cell growth and retinoid production rate of MG1655 was faster than that of DH5 ⁇ .
  • the BL21 (DE3) strain had high cell growth and little retinyl acetate production.
  • DH5 ⁇ and MG1655 were more suitable than the other strains among the six strains.
  • FIG. 13 is a view showing the results of retinoid production and growth according to the concentration of glycerol as a carbon source in the presence of dodecane.
  • a two-phase culture with hydrophobic solvent dodecane was performed for in-situ extraction of retinoids from the cells.
  • Dodecane was selected with low toxicity to E. coli, high hydrophobicity (log P O / W , 6.6) for the extraction of hydrophobic retinoids and no evaporation loss due to low volatility.
  • FIG. 13 shows retinoid production and cell growth of Escherichia coli (pT-DHBSR / pS-NA) in a two-phase culture comprising 1 mL dodecane on 5 mL culture medium. Retinal, retinol and retinyl acetate are shown in light gray, dark gray and black in retinoid production, respectively. Glycerol concentrations 0.5%, 1%, and 2% provided in cell growth are indicated by ⁇ , ⁇ , and ⁇ , respectively.
  • Retinoids were extracted onto dodecane and negligible amounts of retinoids were detected in cell mass and culture (data not shown). As a result, retinoid production was measured from the dodecane phase. As shown in FIG. 13, in-drill extraction by dodecane could minimize intracellular degradation of retinoids. Retinoids in the dodecane phase appeared to be relatively stable and remained without significant oxidative degradation. Compared to the results of FIGS. 9 and 10 (without dodecane addition), the addition of 1 mL of dodecane significantly increased retinoid production even at 24 hours, and retinoid production without cell growth being affected by dodecane addition. The decrease of did not appear in the stationary state.
  • retinoid production in the culture of 2% (w / v) glycerol ranged from 1% (w / v) to 2% (w / v), even though cell growth increased significantly with increasing glycerol concentrations. / v) not higher than that obtained with glycerol. 1 mL of dodecane addition volume may be insufficient for effective retinoid in-drill extraction in culture of 2% (w / v) glycerol.
  • FIG. 14 shows retinoid production and cell growth according to dodecane volume of Escherichia coli (pT-DHBSR / pS-NA) in two-phase culture. Retinal, retinol and retinyl acetate are shown in light gray, dark gray and black in retinoid production, respectively.
  • Dodecane volumes 0 mL, 1 mL, 2 mL, 3 mL, 4 mL, 5 mL, and 6 mL overlayed during cell culture are indicated by ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , ⁇ , and ⁇ , respectively.
  • FIG. 15 shows the distribution of retinoids according to incubation time and dodecane volume as a percentage of each component relative to total retinoids. Retinal, retinol and retinyl acetate are shown in light gray, dark gray and black, respectively.
  • the total retinoid production also improved as the dodecane addition volume increased.
  • the highest retinoid production of 136 mg / L was obtained at 72 hours of incubation with 5 mL dodecane, which was about 2 times higher than with 1 mL dodecane (65 mg / L). Extended cultures for more than 72 hours with 5 mL dodecane resulted in no further increase in retinoid production and maintained its peak without degradation (data not shown).
  • Dodecane addition volume was increased to 6 mL by adding 2 mL of dodecane to the culture at 0, 24, and 48 hours.
  • Figure 15 shows the distribution of retinoids obtained according to the volume of dodecane addition. There is a significant difference in retinoid distribution in the retinal and retinol ratios obtained with and without dodecane addition. At 48 hours, the ratio of retinal in retinoids is about 51% (w / w) in dodecane addition cultures and 23% in cultures without dodecane addition, while the retinol ratio is 30% to 39% in dodecane addition cultures. 59% in culture without dodecane addition. Thus, dodecane addition increases the ratio of retinal but decreases the ratio of retinol.
  • the retinal Given the reaction sequence of retinol formation from the retinal in the cell, the retinal is thought to be extracted from the cell before its conversion to retinol by dodecane.
  • the retinyl acetate ratio at 48 hours is less than 20% in both with and without dodecane addition, which is relatively low compared to retinal and retinol.
  • the retinyl acetate ratio decreases with longer incubation time, indicating that cell activity for retinyl acetate formation decreases during the culture.
  • dodecane addition prevented the reduction of retinoid production and increased retinoid production in the stagnant state of cell growth.
  • In-drill extraction of the retinoids of the present invention does not require lysozyme for cell wall degradation.
  • Retinoids C20, isoprenoid molecules
  • ⁇ -carotene In a two-phase culture of retinoid production, ⁇ -carotene must be maintained in cells because it is a direct precursor of retinoids.
  • BCD (M) O located in the cytosol.
  • ⁇ -carotene cannot be released from cells because of its molecular size and is not extracted by dodecane, it can be maintained in cells in a two-phase culture of ⁇ -carotene (FIG. 16).
  • FIG. 16 shows the effect of dodecane addition on beta-carotene production and cell growth of Escherichia coli with pT-DHB and pS-NA. Cultivation was performed at 29 ° C. for 48 hours with addition of 1 mL dodecane on 5 mL of 2YT medium containing 0.5% (w / v) glycerol and 0.2% (w / v) arabinose. Gray bars and black bars represent 24 and 48 hours, respectively.
  • strain DH5 ⁇ (pT-DHBSR / pSNA) transformed with pT-DHBSR / pSNA to DH5 ⁇
  • 5 ml of octane, decane, dodecane and tetradecane were respectively added to 5 ml medium and subjected to "bacterial strain and culture conditions".
  • the culture was carried out according to the conditions described.
  • As a medium 2YT medium containing 0.2% (w / v) arabinose and 2.0% (w / v) glycerol was used.
  • 17 shows the results of retinoid production in the presence of alkanes.
  • 18 is a diagram showing the results of growth of a retinoid producing strain in the presence of alkanes.
  • Lightweight mineral oils have the advantage of being cheaper than alkanes.
  • strain DH5 ⁇ pT-DHBSR / pSNA
  • pT-DHBSR / pSNA transformed with pT-DHBSR / pSNA to DH5 ⁇
  • adding different volumes of lightweight mineral oil to 5 ml medium, respectively, and cultivating according to the conditions described in "Bacterial strains and culture conditions" It was.
  • As a medium 2YT medium containing 0.2% (w / v) arabinose and 2.0% (w / v) glycerol was used.
  • 19 shows the results of retinoid production in the presence of light mineral oil.
  • 20 is a view showing the growth results of strains in the presence of light mineral oil.
  • FIG. 21 is a diagram showing cell specific retinoids productivity per cell. As shown in FIG. 21, irrespective of the amount of mineral oil, it showed a specific productivity of about 5 mg / L / OD 600 nm.
  • Heavy mineral oils are cheaper than lightweight mineral oils.
  • strain DH5 ⁇ pT-DHBSR / pSNA
  • 2 ml of heavy mineral oil was added to 5 ml medium, respectively, and cultured according to the conditions described in "bacterial strains and culture conditions".
  • As a medium 2YT medium containing 0.2% (w / v) arabinose and 2.0% (w / v) glycerol was used.
  • FIG. 22 shows the results of retinoid production in the presence of heavy mineral oil.
  • Fig. 23 shows the growth results of strains in the presence of heavy mineral oil.
  • the light mineral oil and the heavy mineral oil had less cell growth than dodecane.
  • 104.6 mg / L of retinoids were produced. This is expected to be due to the poor mixing of the medium and the mineral oil due to the viscosity of the heavy mineral oil.
  • the cells were cultured in the same manner as above except that the test tubes used were tilted and placed in the incubator. By tilting the test tube, the effect of agitation was increased, allowing the medium and mineral oil to mix better.
  • Figure 24 is a view showing the results of retinoid production when incubated with test tubes.
  • 25 is a view showing the results of strain growth when cultured by tilting the test tube. As shown in FIG. 24 and FIG. 25, the cell growth and the retinoid production increased when the culture was inclined. Specifically, when the test tube was upright, 88.2 mg / L retinoids were produced at 96 hours, but when the test tube was tilted, 173.9 mg / L was produced.
  • Retinoids were produced in media containing skin friendly lipophilic substances.
  • Skin-friendly lipophilic materials used isopropyl myristate (IPM), dioctanoyl-decanoyl glycerol (ODO), cetyl ethylhexanoate (CEH), and phytosqualane.
  • strain DH5 ⁇ (pT-DHBSR / pSNA) transformed with pT-DHBSR / pSNA to DH5 ⁇
  • 2 ml of heavy mineral oil was added to 5 ml medium, respectively, and cultured according to the conditions described in "bacterial strains and culture conditions".
  • As a medium 2YT medium containing 0.2% (w / v) arabinose and 2.0% (w / v) glycerol was used.
  • the control group was added 5 ml of dodecane.
  • FIG. 26 shows cell growth and pH in the presence of skin friendly lipophilic material.
  • FIG. 27 and 28 are diagrams showing the results of retinoid production according to the amount of skin-friendly lipophilic material. As shown in FIG. 27 and FIG. 28, the amount of retinoid production was higher at 2 mL compared to 5 mL in the lipophilic substance except dodecane. That is, when about 2 mL was used with respect to 5 mL of the medium of light mineral oil, IPM, ODO, CEH, and phytoscualan, the retinoid production amount was large. Among the IPM, ODO, CEH and phytosqualane, the most retinoids were produced in IPM. In particular, when 2 mL of IPM was added, 180 mg / L retinoids were produced. In the case of IPM, considering the similar cell growth, the specific productivity per cell is expected to be high.

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de production d'un rétinoïde par un micro-organisme et, plus précisément, un procédé permettant d'obtenir de manière efficace un rétinoïde qui est instable. Le procédé comprend la culture du micro-organisme capable de produire un rétinoïde dans un milieu contenant une substance lipophile et la séparation du rétinoïde de la substance lipophile.
PCT/KR2012/006071 2011-07-29 2012-07-30 Procédé de production d'un rétinoïde par un micro-organisme Ceased WO2013019051A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/235,841 US9644217B2 (en) 2011-07-29 2012-07-30 Method for producing retinoid from microorganism
CN201280042839.0A CN103857786B (zh) 2011-07-29 2012-07-30 从微生物中制造类视黄醇的方法
US15/180,032 US9834794B2 (en) 2011-07-29 2016-06-12 Method for producing retinoid from microorganism

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20110075715 2011-07-29
KR10-2011-0075715 2011-07-29
KR1020120083185A KR101392159B1 (ko) 2011-07-29 2012-07-30 미생물로부터 레티노이드를 생산하는 방법
KR10-2012-0083185 2012-07-30

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/235,841 A-371-Of-International US9644217B2 (en) 2011-07-29 2012-07-30 Method for producing retinoid from microorganism
US15/180,032 Continuation US9834794B2 (en) 2011-07-29 2016-06-12 Method for producing retinoid from microorganism

Publications (3)

Publication Number Publication Date
WO2013019051A2 true WO2013019051A2 (fr) 2013-02-07
WO2013019051A9 WO2013019051A9 (fr) 2013-05-02
WO2013019051A3 WO2013019051A3 (fr) 2013-06-20

Family

ID=47629791

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/006071 Ceased WO2013019051A2 (fr) 2011-07-29 2012-07-30 Procédé de production d'un rétinoïde par un micro-organisme

Country Status (1)

Country Link
WO (1) WO2013019051A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105308172A (zh) * 2013-06-20 2016-02-03 庆尚大学校产学协力团 包含编码参与产生类视色素的酶的基因的微生物和使用其生产类视色素的方法
EP3623480A4 (fr) * 2017-05-11 2021-02-24 Industry-Academic Cooperation Foundation Gyeongsang National University Composition de marqueur pour sélectionner un organisme modifié vivant, organisme modifié vivant et procédé de transformation
EP3907290A4 (fr) * 2018-11-30 2022-09-28 Biosplash Co., Ltd. Micro-organisme produisant du biorétinol et procédé de production de biorétinol l'utilisant
WO2023085688A1 (fr) 2021-11-09 2023-05-19 경상국립대학교산학협력단 Composition pour la préparation de rétinoïde et procédé de préparation de rétinoïde l'utilisant
EP4403627A3 (fr) * 2017-02-24 2024-10-16 Agency for Science, Technology and Research Production de caroténoïdes et d'apocaroténoïdes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100971508B1 (ko) * 2008-01-14 2010-07-21 경상대학교산학협력단 이소프레노이드 생산성이 향상된 에세리키아 속 미생물 및그를 이용하여 이소프레노이드를 생산하는 방법

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105308172A (zh) * 2013-06-20 2016-02-03 庆尚大学校产学协力团 包含编码参与产生类视色素的酶的基因的微生物和使用其生产类视色素的方法
US10030258B2 (en) 2013-06-20 2018-07-24 Industrial-Academic Cooperation Foundation Gyeongsang National University Microorganism comprising gene for coding enzyme involved in producing retinoid and method for producing retinoid by using same
EP4403627A3 (fr) * 2017-02-24 2024-10-16 Agency for Science, Technology and Research Production de caroténoïdes et d'apocaroténoïdes
US12378561B2 (en) 2017-02-24 2025-08-05 Agency For Science, Technology And Research Production of carotenoids and apocarotenoids
EP3623480A4 (fr) * 2017-05-11 2021-02-24 Industry-Academic Cooperation Foundation Gyeongsang National University Composition de marqueur pour sélectionner un organisme modifié vivant, organisme modifié vivant et procédé de transformation
US11549117B2 (en) 2017-05-11 2023-01-10 Industry-Academic Cooperation Foundation Gyeongsang National University Marker composition for selecting living modified organism, living modified organism, and transformation method
EP3907290A4 (fr) * 2018-11-30 2022-09-28 Biosplash Co., Ltd. Micro-organisme produisant du biorétinol et procédé de production de biorétinol l'utilisant
WO2023085688A1 (fr) 2021-11-09 2023-05-19 경상국립대학교산학협력단 Composition pour la préparation de rétinoïde et procédé de préparation de rétinoïde l'utilisant

Also Published As

Publication number Publication date
WO2013019051A3 (fr) 2013-06-20
WO2013019051A9 (fr) 2013-05-02

Similar Documents

Publication Publication Date Title
WO2014204058A1 (fr) Micro-organisme comprenant un gène codant pour une enzyme impliquée dans la production de rétinoïde et procédé pour la production de rétinoïde à l'aide de celui-ci
Ruther et al. Production of zeaxanthin in Escherichia coli transformed with different carotenogenic plasmids
WO2020111890A1 (fr) Micro-organisme produisant du biorétinol et procédé de production de biorétinol l'utilisant
US9834794B2 (en) Method for producing retinoid from microorganism
Hausmann et al. A single five-step desaturase is involved in the carotenoid biosynthesis pathway to β-carotene and torulene in Neurospora crassa
WO2013019051A2 (fr) Procédé de production d'un rétinoïde par un micro-organisme
WO2020141168A1 (fr) Nouvelles acétyl-transférases
WO2022090548A1 (fr) Production par fermentation d'isoprénoïdes
WO2012026665A1 (fr) Nouveaux dérivés de tacrolimus, composition neuroprotectrice les comprenant, composition immunosuppressive les comprenant, procédé pour leur préparation et mutant pour leur production
WO2019132510A2 (fr) Levure recombinante ayant un organite muté et procédé de production d'isoprénoïdes l'utilisant
Ortega-Ramos et al. Engineered biosynthesis of bacteriochlorophyll gF in Rhodobacter sphaeroides
Lutnaes et al. Carotenoids of thermophilic bacteria—Rhodothermus marinus from submarine Icelandic hot springs
WO2022003130A2 (fr) Système d'expression de levure
WO2013019053A9 (fr) Micro-organisme du genre escherichia ne contenant pas le gène eute ou le gène puuc et procédé de production de rétinoïde faisant appel à ce micro-organisme
KR20210033100A (ko) 효소반응을 이용한 크로신-4의 생산방법
Asaka et al. Major Carotenoids of Meiothermus ruber Are Deinoxanthin Glucoside Esters, Not Meiothermoxanthin Glucoside Esters
WO2013019052A2 (fr) Micro-organisme du genre escherichia contenant ou ne contenant pas un gène ybbo amplifié et procédé de production de rétinoïde faisant appel à ce micro-organisme
Chen et al. Engineering a non-model yeast Rhodotorula mucilaginosa for terpenoids synthesis
AU2022257089A9 (en) Methods of isoprenoid synthesis using a genetically engineered hydrocarbonoclastic organism in a biofilm bioreactor
WO2011162447A1 (fr) Micro-organisme pouvant croître et produire une substance utile dans un environnement de résidus de glycérol
Mehta et al. Lycopene cyclization in Blakeslea trispora
JP2006507009A (ja) ユビキノンの製造
WO2018212366A1 (fr) Levure recombinante pour la production de 2,3-butanediol dans laquelle est introduite une pyruvate décarboxylase dérivée de candida tropicalis et procédé de production de 2,3-butanediol l'utilisant
WO2021080277A1 (fr) Nouvelle enzyme pour la production de d-thréonine, et procédé de production stéréospécifique de d-thréonine l'utilisant
WO2018182334A1 (fr) Procédé de préparation d'une souche mutante présentant une productibilité élevée de phytoène et souche mutante ainsi préparée

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201280042839.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12820328

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14235841

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 12820328

Country of ref document: EP

Kind code of ref document: A2